Exelixis (EXEL) Change in Acquisitions & Divestments (2010 - 2026)

Exelixis' (EXEL) quarterly Change in Acquisitions & Divestments came in at $225.1 million in Q2 2026, down 13.05% year-on-year from $258.9 million in Q2 2025, and up 18.9% quarter-over-quarter from $189.3 million in Q1 2026.

Exelixis (EXEL) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Exelixis' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $225.1 million for Q2 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 13.05% year-over-year to $225.1 million in Q2 2026; TTM through Apr 2026 was $989.1 million, a 13.98% increase from a year earlier, with the FY2026 full-year figure at $1.0 billion, up 16.59% from the prior year.
  • Change in Acquisitions & Divestments rose to $225.1 million in Q2 2026 per EXEL's latest filing, from $189.3 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $353.1 million in Q3 2025 and bottomed at $153.5 million in Q4 2023.
  • The 5-year median for Change in Acquisitions & Divestments is $238.0 million (2022), against an average of $248.7 million.
  • Across the five-year window, Change in Acquisitions & Divestments slumped 46.18% in 2024 and soared 64.02% in 2025, its largest moves.
  • Year by year, Change in Acquisitions & Divestments stood at $238.0 million in 2022, then plunged by 35.5% to $153.5 million in 2023, then rose by 9.07% to $167.4 million in 2024, then surged by 32.31% to $221.5 million in 2025, then increased by 1.63% to $225.1 million in 2026.
  • Per Business Quant, the three latest EXEL Change in Acquisitions & Divestments figures stand at $225.1 million (Q2 2026), $189.3 million (Q1 2026), and $221.5 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,320.50 Bn 66,320.21 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.93 Bn 468.14 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.22 Bn 114.98 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.96 Bn 61.21 Bn 3.31 Bn
7 Belite Bio 62.66 Bn 62.66 Bn -
8 Argenx Se 56.07 Bn 50.89 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.60 Bn 34.59 Bn 959.66 Mn
10 Exelixis 14.48 Bn 13.70 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 225.13 Mn
Apr 3, 2026 225.13 Mn
Jan 2, 2026 189.34 Mn
Jan 2, 2026 189.34 Mn
Oct 3, 2025 221.51 Mn
Oct 3, 2025 221.51 Mn
Jul 4, 2025 353.10 Mn
Jul 4, 2025 353.10 Mn
Apr 4, 2025 258.92 Mn
Apr 4, 2025 258.92 Mn
Jan 3, 2025 226.16 Mn
Jan 3, 2025 226.16 Mn
Sep 27, 2024 167.42 Mn
Sep 27, 2024 167.42 Mn
Jun 28, 2024 215.28 Mn
Jun 28, 2024 215.28 Mn
Mar 29, 2024 268.45 Mn
Mar 29, 2024 268.45 Mn
Dec 29, 2023 153.49 Mn
Dec 29, 2023 153.49 Mn